Results 31 to 40 of about 80,157 (261)

Epigallocatechin Gallate-Modified Silver Nanoparticles Show Antiviral Activity against Herpes Simplex Type 1 and 2

Viruses, 2023
(1) Background: Epigallocatechin gallate (EGCG) has been recognized as a flavonoid showing antiviral activity against various types of DNA and RNA viruses.
Malgorzata Krzyzowska, Martyna Janicka, Marcin Chodkowski, Magdalena Patrycy, Oliwia Obuch-Woszczatyńska, Emilia Tomaszewska, Katarzyna Ranoszek-Soliwoda, Grzegorz Celichowski, Jaroslaw Grobelny   +8 more
doaj   +1 more source

LAT region factors mediating differential neuronal tropism of HSV-1 and HSV-2 do not act in trans. [PDF]

PLoS ONE, 2012
After HSV infection, some trigeminal ganglion neurons support productive cycle gene expression, while in other neurons the virus establishes a latent infection.
Andrea S Bertke, Kathleen Apakupakul, AyeAye Ma, Yumi Imai, Anne M Gussow, Kening Wang, Jeffrey I Cohen, David C Bloom, Todd P Margolis   +8 more
doaj   +1 more source

HSV-2 Induced Cerebellitis: A Case Report of HSV-2 Reactivation by SARS-CoV-2 Infection

The Open Neurology Journal, 2023
Background: Herpes simplex virus type 2 rarely causes encephalitis in humans. Some DNA viruses, such as HSV-1 and HSV-2, can be reactivated by COVID-19 infection. SARS-CoV-2 causes a wide spectrum of neurological deficits, such as stroke, delirium, movement disorders, and neuropathy. Case Presentation: An
Fahimeh Ehsanipur, Mohammad Vafaee-Shahi, Leila Tahernia, Aina Riahi   +3 more
openaire   +1 more source

Detection of Viruses associated with Herpes Labialis Patients in Babylon Province Pre and Post Treatment with Low Power Laser Therapy (Diode Laser)

Medical Journal of Babylon
Background:The secondary or recurrent herpetic infections (RHIs) are caused by herpes simplex virus (HSV) type-1 and type-2. low-power laser therapy 940 nm may consider one of the best and most optimistic and optional local therapeutic and biological ...
Ahmed Jaber Aboob, Ali Mihsen Hussein Alyassiri, Younis Abdulridha Alkhafaji   +2 more
doaj   +1 more source

Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007. [PDF]

PLoS ONE, 2015
Herpes simplex virus type 1 (HSV-1) and 2 (HSV-2) are common human pathogens and might cause severe illness. Following primary infection, the viruses establish lifelong latent infection and are transmitted by close contact, both sexual and nonsexual ...
Jen-Hsiang Shen, Kuan-Ying Arthur Huang, Chen Chao-Yu, Chih-Jung Chen, Tzou-Yien Lin, Yhu-Chering Huang   +5 more
doaj   +1 more source

Vaginal HSV-2 Infection and Tissue Analysis [PDF]

BIO-PROTOCOL, 2017
The vaginal murine HSV-2 infection model is very useful in studying mucosal immunity against HSV-2 ( Overall et al., 1975 ; Renis et al., 1976 ; Parr and Parr, 2003). Histologically, the vagina of Depo-Provera-treated mice is lined by a single layer of mucus secreting columnar epithelial cells overlying two to three layers of proliferative cells.
Marie Iversen, Søren Paludan, Christian Holm   +2 more
openaire   +3 more sources

Inactivating and inhibitory activity of dry ethanol extracts of wormwood (Artemisia spp.) on herpes simplex virus of the 2 type in vitro

Юг России: экология, развитие
Aim. In vitro assessment of the inactivating and inhibitory activity of dry ethanol extracts of various wormwood species (Artemisia spp.) native to the Novosibirsk region and Altai Republic on the replication of Herpes simplex virus type 2 (HSV-2 ...
E. I. Каzachinskaia, V. V. Velichko, V. D. Romanova, D. S. Kruglov, D. L. Prokusheva, A. A. Chepurnov, Yu. V. Коnonova, L. Fu, Sh. Shao, M. A. Gulyaeva, A. M. Shestopalov   +10 more
doaj   +1 more source

Herpes Simplex Virus 1 and 2 Infections during Differentiation of Human Cortical Neurons

Viruses, 2021
Herpes simplex virus 1 (HSV-1) and 2 (HSV-2) can infect the central nervous system (CNS) with dire consequences; in children and adults, HSV-1 may cause focal encephalitis, while HSV-2 causes meningitis.
Petra Bergström, Edward Trybala, Charlotta E. Eriksson, Maria Johansson, Tugce Munise Satir, Sibylle Widéhn, Stefanie Fruhwürth, Wojciech Michno, Faisal Hayat Nazir, Jörg Hanrieder, Soren Riis Paludan, Lotta Agholme, Henrik Zetterberg, Tomas Bergström   +13 more
doaj   +1 more source

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection.

PLoS Pathogens, 2020
HSV-1 causes 50% of first-time genital herpes infections in resource-rich countries and affects 190 million people worldwide. A prophylactic herpes vaccine is needed to protect against genital infections by both HSV-1 and HSV-2. Previously our laboratory
Kevin P Egan, Lauren M Hook, Alexis Naughton, Norbert Pardi, Sita Awasthi, Gary H Cohen, Drew Weissman, Harvey M Friedman   +7 more
doaj   +1 more source

A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine. [PDF]

PLoS ONE, 2011
Glycoprotein D (gD-2) is the entry receptor of herpes simplex virus 2 (HSV-2), and is the immunogen in the pharmaceutical industry's lead HSV-2 vaccine candidate.
William P Halford, Ringo Püschel, Edward Gershburg, Andrew Wilber, Svetlana Gershburg, Brandon Rakowski   +5 more
doaj   +1 more source